Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

HIV-1 envelope gp41 broadly neutralizing antibodies: hurdles for vaccine development.

PLoS pathogens - 1 May 2014

Verkoczy Laurent, Kelsoe Garnett, Haynes Barton F

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to AIDS Vaccines
Share to Antibodies, Neutralizing
Share to Autoantibodies
Share to Drug Discovery

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to HIV Antibodies

Share to HIV Envelope Protein gp41

Share to HIV Infections

Share to Immune Tolerance

Source

Open in PubMed Open full text

Identifiers

PMID: 24853821
DOI: 10.1371/journal.ppat.1004073
PMCID: PMC4031215

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

HIV-1 envelope gp41 broadly neutralizing antibodies: hurdles for vaccine development.PMID 24853821Read ↗

Broadly neutralizing antibodies against HIV-1: Templates for a vaccineSemantic proximity Read ↗

HIV-neutralizing antibodies: epitope identification and significance for future vaccine.Semantic proximity Read ↗

Germline-like predecessors of broadly neutralizing antibodies lack measurable binding to HIV-1 envelope glycoproteins: Implications for evasion of immune responses and design of vaccine immunogensSemantic proximity Read ↗

Harnessing the protective potential of HIV-1 neutralizing antibodiesSemantic proximity Read ↗

Catch Me If You Can--The Race Between HIV and Neutralizing Antibodies.Semantic proximity Read ↗

<scp>HIV</scp>‐1 neutralizing antibodies: understanding nature's pathwaysSemantic proximity Read ↗

Broadly Neutralizing Antibodies against HIV: Back to BloodSemantic proximity Read ↗

The changing face of HIV vaccine research.Semantic proximity Read ↗

Broadly Neutralizing Antibodies to HIV and Their Role in Vaccine DesignSemantic proximity Read ↗

GP120: Target for Neutralizing HIV-1 AntibodiesSemantic proximity Read ↗

Rational Modifications of HIV-1 Envelope Glycoproteins for Immunogen DesignSemantic proximity Read ↗

Broadly Neutralizing Antibodies for HIV EradicationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.